Preclinical Trial of Rituxan-Generated, Pre-Apoptotic Redox Regulation in CLL, Lymphoma & Myeloma Cell Lines

Project: Research project

Project Details

StatusFinished
Effective start/end date12/18/0312/31/11

Funding

  • Biogen Inc. (Agreement 12/18/2003)